Roger Cady Selected Research

butalbital

4/2012	Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
5/2004	Migraine headache misconceptions: barriers to effective care.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger Cady Research Topics

Disease

62	Migraine Disorders (Migraine) 07/2022 - 01/2002
26	Headache (Headaches) 07/2022 - 01/2003
18	Pain (Aches) 07/2022 - 05/2004
6	Nausea 06/2022 - 01/2002
5	Photophobia (Light Sensitivity) 06/2022 - 01/2002
4	Hyperacusis (Phonophobia) 06/2022 - 01/2002
3	Secondary Headache Disorders 10/2021 - 04/2012
3	Headache Disorders (Headache Syndromes) 01/2011 - 05/2002
2	Epilepsy (Aura) 01/2022 - 01/2006
2	Hypersensitivity (Allergy) 03/2021 - 01/2021
2	Nasopharyngitis 03/2021 - 01/2020
2	Fatigue 01/2020 - 01/2011
2	Vertigo (Positional Vertigo) 04/2016 - 04/2006
2	Dizziness (Lightheadedness) 01/2011 - 04/2006
1	Migraine with Aura (Familial Hemiplegic Migraine) 01/2022
1	Pruritus (Itching) 03/2021
1	Exanthema (Rash) 03/2021
1	Urticaria (Hives) 03/2021
1	Flushing 03/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Ovarian Cysts (Ovarian Cyst) 04/2016
1	Sleepiness 04/2015
1	Ganglion Cysts (Ganglion) 01/2015
1	Disease Progression 01/2014
1	Neurogenic Inflammation 04/2012
1	Paresthesia (Dysesthesia) 01/2011
1	Dysmenorrhea (Menstrual Pain) 05/2010
1	Cluster Headache (Cluster Headaches) 08/2006
1	Injection Site Reaction 04/2006
1	Migraine without Aura (Common Migraine) 01/2006
1	Wounds and Injuries (Trauma) 02/2005
1	Vascular Diseases (Vascular Disease) 05/2004
1	Tension-Type Headache (Tension Headache) 05/2004
1	Botulism 01/2004
1	Paralysis (Palsy) 01/2004
1	Vomiting 01/2002

Drug/Important Bio-Agent (IBA)

26	eptinezumabIBA 07/2022 - 08/2019
15	Calcitonin Gene-Related PeptideIBA 07/2022 - 01/2004
14	Monoclonal AntibodiesIBA 07/2022 - 04/2016
12	Sumatriptan (Imigran)FDA LinkGeneric 01/2015 - 01/2002
11	Tryptamines (Triptans)IBA 01/2015 - 03/2002
8	TabletsIBA 01/2014 - 01/2003
6	Naproxen (Naprosyn)FDA LinkGeneric 01/2014 - 05/2010
5	Pain-FreeIBA 01/2014 - 09/2004
5	rizatriptan (Maxalt)FDA Link 02/2009 - 10/2004
4	Type A Botulinum Toxins (Botox)FDA Link 02/2014 - 01/2004
3	Pharmaceutical PreparationsIBA 01/2015 - 02/2009
3	Analgesics (Analgesic Drugs)IBA 03/2005 - 03/2002
2	Therapeutic UsesIBA 04/2012 - 04/2006
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2012 - 03/2005
2	butalbital FDA LinkGeneric 04/2012 - 05/2004
2	Topiramate (Topamax)FDA LinkGeneric 01/2011 - 09/2006
1	Neutralizing AntibodiesIBA 01/2021
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 12/2020
1	AntibodiesIBA 07/2018
1	erenumabIBA 04/2016
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 04/2016
1	MK-6096IBA 04/2015
1	Orexin ReceptorsIBA 04/2015
1	Orexin Receptor AntagonistsIBA 04/2015
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2015
1	Caffeine (No Doz)FDA LinkGeneric 04/2012
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2012
1	sumatriptan-naproxen FDA Link 04/2012
1	Substance PIBA 04/2012
1	AntiemeticsIBA 04/2012
1	Opioid Analgesics (Opioids)IBA 04/2012
1	preemptIBA 11/2011
1	NeurotoxinsIBA 11/2011
1	ProstaglandinsIBA 05/2010
1	Biological ProductsIBA 08/2006
1	Dihydrotachysterol (AT 10)IBA 04/2006
1	Serotonin (5 Hydroxytryptamine)IBA 03/2005
1	Ergot AlkaloidsIBA 03/2005
1	Nonprescription Drugs (Patent Medicines)IBA 01/2005
1	frovatriptan (Allegro)FDA Link 09/2004
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2004
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2004
1	NeuropeptidesIBA 01/2004
1	Nasal SpraysIBA 01/2003
1	Biomarkers (Surrogate Marker)IBA 05/2002
1	almotriptan (Axert)FDA Link 01/2002

Therapy/Procedure

13	Therapeutics 01/2021 - 03/2002
3	Aftercare (After-Treatment) 02/2022 - 05/2005
2	Treatment Delay 06/2006 - 05/2005
1	Intravenous Infusions 01/2022
1	Intravenous Administration 03/2021
1	Intranasal Administration 01/2015